SignatureFD’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

SignatureFD’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-119	Closed	-$2K	–	3357
2021 Q3	$2K	Sell	119 -50	-30%	-$1.38K	﹤0.01%	2751
2021 Q2	$6K	Buy	169 +92	+119%	+$2.82K	﹤0.01%	2248
2021 Q1	$2K	Hold	77	–	–	﹤0.01%	2568
2020 Q4	$2K	Buy	77 +24	+45%	+$529	﹤0.01%	2355
2020 Q3	$1K	Buy	53 +12	+29%	+$248	﹤0.01%	2550
2020 Q2	$1K	Buy	+41	New	+$883	﹤0.01%	2448

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

SignatureFD's DRNA Position: Q4 2021 in Review

SignatureFD sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 119 shares — an estimated $2K sold.

SignatureFD first reported a position in DRNA in Q2 2020 and held it in 6 quarters. The position peaked at $6K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

SignatureFD reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
SignatureFD sold 119 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2K.
SignatureFD first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2020 and held it in 6 quarters.
SignatureFD's Dicerna Pharmaceuticals, Inc. position peaked at $6K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.